ZA200801742B - Bazedoxifene acetate formulations and manufacturing process thereof - Google Patents

Bazedoxifene acetate formulations and manufacturing process thereof

Info

Publication number: ZA200801742B
Authority: ZA; South Africa
Prior art keywords: manufacturing process; bazedoxifene acetate; acetate formulations; formulations; bazedoxifene
Prior art date: 2005-08-24

Application number

ZA200801742A

Other languages

English (en)

Inventor

Syed M Shah

Eric C Ehrnsperger

Christopher R Diorio

Kadum A Ali

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-24

Filing date

2008-02-22

Publication date

2010-10-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37772333&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200801742(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-22 Application filed by Wyeth Llc filed Critical Wyeth Llc

2010-10-27 Publication of ZA200801742B publication Critical patent/ZA200801742B/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

ZA200801742A 2005-08-24 2008-02-22 Bazedoxifene acetate formulations and manufacturing process thereof ZA200801742B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US71076105P	2005-08-24	2005-08-24

Publications (1)

Publication Number	Publication Date
ZA200801742B true ZA200801742B (en)	2010-10-27

Family

ID=37772333

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200801742A ZA200801742B (en)	2005-08-24	2008-02-22	Bazedoxifene acetate formulations and manufacturing process thereof

Country Status (21)

Country	Link
US (1)	US7771744B2 (xx)
EP (1)	EP1919456A2 (xx)
JP (2)	JP2009506053A (xx)
KR (2)	KR101584674B1 (xx)
CN (1)	CN101304731B (xx)
AR (1)	AR056471A1 (xx)
AU (1)	AU2006283121A1 (xx)
BR (1)	BRPI0615341A2 (xx)
CA (1)	CA2620174A1 (xx)
CR (1)	CR9746A (xx)
EC (1)	ECSP088214A (xx)
GT (1)	GT200600383A (xx)
IL (2)	IL189648A (xx)
MX (1)	MX2008002484A (xx)
NO (1)	NO20080991L (xx)
PE (1)	PE20070425A1 (xx)
RU (1)	RU2417084C2 (xx)
SV (1)	SV2008002825A (xx)
TW (1)	TW200738281A (xx)
WO (1)	WO2007024961A2 (xx)
ZA (1)	ZA200801742B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA06011685A (es) *	2004-04-08	2006-12-14	Wyeth Corp	Formulaciones de dispersiones solidas de acetato de bazedoxifeno.
AU2006283121A1 (en) *	2005-08-24	2007-03-01	Wyeth	Bazedoxifene acetate formulations and manufacturing process thereof
AU2007232098A1 (en) *	2006-03-31	2007-10-11	Rubicon Research Private Limited	Directly compressible composite for orally disintegrating tablets
WO2008079342A2 (en) *	2006-12-21	2008-07-03	Mallinckrodt Inc.	Composition of and method for preparing orally disintegrating tablets
US20100016582A1 (en) *	2008-02-11	2010-01-21	Wyeth	Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate
ITMI20091109A1 (it)	2009-06-23	2010-12-24	Wyeth Corp	Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
CA2818068C (en) *	2010-11-30	2019-06-11	Wista Laboratories Ltd.	Formulations comprising methylthioninium chloride
EP2471770A1 (en) *	2010-12-28	2012-07-04	Sandoz Ag	Method of preparing polymorphic pure form A of bazedoxifene acetate
WO2013182170A1 (en)	2012-06-07	2013-12-12	Zentiva, K. S.	Enhancement of dissolution rate from pharmaceutical composition comprising bazedoxifene acetate
WO2013182169A1 (en)	2012-06-07	2013-12-12	Zentiva, K. S.	Process of preparation of an antioxidant-free polymorphically and chemically stable formulation of bazedoxifene acetate
CN103877581B (zh) *	2014-03-24	2016-03-02	江苏知原药业有限公司	一种性能优异的乙酸巴多昔芬缓释制剂
WO2018182205A1 (ko) *	2017-03-30	2018-10-04	한미약품 주식회사	바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
KR101940569B1 (ko) *	2017-05-24	2019-01-21	아주대학교산학협력단	바제독시펜 또는 이의 약학적으로 허용가능한 염을 포함하는 약학 조성물
CN112076163B (zh) *	2019-06-14	2023-06-20	四川科伦药物研究院有限公司	一种醋酸巴多昔芬片的药物组合物及其制备方法
CN111004165A (zh) *	2019-12-03	2020-04-14	南京正济医药研究有限公司	一种醋酸巴多昔芬晶型a的制备方法
CN112754999A (zh) *	2021-01-23	2021-05-07	郑州泰丰制药有限公司	一种醋酸巴多昔芬组合物及醋酸巴多昔芬薄膜衣片制备方法
CN113368075A (zh) *	2021-06-29	2021-09-10	郑州泰丰制药有限公司	一种醋酸巴多昔芬片及其制备方法
CA3229700A1 (en) *	2021-08-23	2023-03-02	Jan Brabek	Treatment of covid-19

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5686094A (en) *	1991-04-01	1997-11-11	Theratech, Inc.	Controlled release formulations for the treatment of xerostomia
CN1119998C (zh) *	1995-06-22	2003-09-03	阿克佐诺贝尔公司	去氧孕烯的压制干颗粒片
US5998402A (en) *	1996-04-19	1999-12-07	American Home Products Corporation	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) *	1998-05-15	2002-11-12	Wyeth	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
CN1429222A (zh)	2000-02-17	2003-07-09	安姆根有限公司	激酶抑制剂
AR029538A1 (es) *	2000-07-06	2003-07-02	Wyeth Corp	Composiciones farmaceuticas de agentes estrogenicos
SE0104140D0 (sv)	2001-12-07	2001-12-07	Astrazeneca Ab	Novel Compounds
CN1658868A (zh) *	2002-06-13	2005-08-24	惠氏公司	巴泽昔芬治疗方案
RU2006123939A (ru)	2004-01-13	2008-02-20	Вайет (Us)	Лечение остеопороза, связанного с терапией ингибиторами ароматазы
JP2007532548A (ja)	2004-04-07	2007-11-15	ワイス	バゼドキシフェンアセテートの結晶質多形体
SG151331A1 (en)	2004-04-07	2009-04-30	Wyeth Corp	Crystalline polymorph of a bazedoxifene acetate
CN1938272A (zh) *	2004-04-07	2007-03-28	惠氏公司	巴泽多昔芬醋酸盐的结晶多晶型物
MXPA06011685A (es) *	2004-04-08	2006-12-14	Wyeth Corp	Formulaciones de dispersiones solidas de acetato de bazedoxifeno.
AU2006283121A1 (en) *	2005-08-24	2007-03-01	Wyeth	Bazedoxifene acetate formulations and manufacturing process thereof

2006
- 2006-08-23 AU AU2006283121A patent/AU2006283121A1/en not_active Abandoned
- 2006-08-23 CA CA002620174A patent/CA2620174A1/en not_active Abandoned
- 2006-08-23 MX MX2008002484A patent/MX2008002484A/es active IP Right Grant
- 2006-08-23 JP JP2008528116A patent/JP2009506053A/ja not_active Withdrawn
- 2006-08-23 CN CN2006800394740A patent/CN101304731B/zh not_active Expired - Fee Related
- 2006-08-23 AR ARP060103666A patent/AR056471A1/es not_active Application Discontinuation
- 2006-08-23 KR KR1020087006992A patent/KR101584674B1/ko active IP Right Grant
- 2006-08-23 PE PE2006001025A patent/PE20070425A1/es not_active Application Discontinuation
- 2006-08-23 WO PCT/US2006/032935 patent/WO2007024961A2/en active Application Filing
- 2006-08-23 KR KR1020147017847A patent/KR20140088917A/ko not_active Application Discontinuation
- 2006-08-23 TW TW095130979A patent/TW200738281A/zh unknown
- 2006-08-23 BR BRPI0615341-0A patent/BRPI0615341A2/pt not_active Application Discontinuation
- 2006-08-23 RU RU2008107580/15A patent/RU2417084C2/ru active
- 2006-08-23 GT GT200600383A patent/GT200600383A/es unknown
- 2006-08-23 US US11/508,801 patent/US7771744B2/en active Active
- 2006-08-23 EP EP06802170A patent/EP1919456A2/en not_active Withdrawn
2008
- 2008-02-19 CR CR9746A patent/CR9746A/es not_active Application Discontinuation
- 2008-02-21 IL IL189648A patent/IL189648A/en active IP Right Grant
- 2008-02-22 EC EC2008008214A patent/ECSP088214A/es unknown
- 2008-02-22 SV SV2008002825A patent/SV2008002825A/es not_active Application Discontinuation
- 2008-02-22 ZA ZA200801742A patent/ZA200801742B/xx unknown
- 2008-02-27 NO NO20080991A patent/NO20080991L/no not_active Application Discontinuation
2013
- 2013-06-11 JP JP2013122658A patent/JP2013209419A/ja active Pending
2014
- 2014-06-26 IL IL233392A patent/IL233392A/en active IP Right Grant

Also Published As

Publication number	Publication date
MX2008002484A (es)	2008-04-07
IL189648A0 (en)	2008-08-07
KR20080043853A (ko)	2008-05-19
IL189648A (en)	2014-07-31
JP2009506053A (ja)	2009-02-12
US20070048374A1 (en)	2007-03-01
AU2006283121A1 (en)	2007-03-01
WO2007024961A2 (en)	2007-03-01
US7771744B2 (en)	2010-08-10
NO20080991L (no)	2008-05-15
JP2013209419A (ja)	2013-10-10
CN101304731A (zh)	2008-11-12
CA2620174A1 (en)	2007-03-01
GT200600383A (es)	2007-03-29
TW200738281A (en)	2007-10-16
KR20140088917A (ko)	2014-07-11
BRPI0615341A2 (pt)	2011-05-17
CN101304731B (zh)	2012-06-20
SV2008002825A (es)	2008-06-30
EP1919456A2 (en)	2008-05-14
CR9746A (es)	2008-08-21
AR056471A1 (es)	2007-10-10
KR101584674B1 (ko)	2016-01-13
IL233392A (en)	2017-02-28
WO2007024961A3 (en)	2007-06-28
IL233392A0 (en)	2014-08-31
RU2008107580A (ru)	2009-09-27
RU2417084C2 (ru)	2011-04-27
PE20070425A1 (es)	2007-07-02
ECSP088214A (es)	2008-03-26

Publication	Publication Date	Title
ZA200801742B (en)	2010-10-27	Bazedoxifene acetate formulations and manufacturing process thereof
EP1889304A4 (en)	2011-08-10	COMPOSITIONS AND THERMOELECTRIC PROCESS
IL191759A0 (en)	2008-12-29	Ganaxolone formulations and methods for the making and use thereof
EP1734637A4 (en)	2010-11-03	ROTOR AND PROCESS FOR ITS MANUFACTURE
IL185199A0 (en)	2008-01-06	Indole compound and use thereof
IL185280A0 (en)	2008-02-09	Tetrahydroindolone and tetrahydroindazolone derivatives
EP1895838A4 (en)	2013-03-06	COMPOSITIONS AND METHODS
IL191482A0 (en)	2009-02-11	Novel process and formulations
PT1922309E (pt)	2014-09-02	Derivados de n-fenil-2-pirimidina-amina e processo para a sua preparação
TWI350122B (en)	2011-10-01	Ceramic heater and manufacturing method thereof
IL184834A0 (en)	2007-12-03	Compositions and methods for the manufacture thereof
HK1120660A1 (en)	2009-04-03	Electrode and manufacturing methods
IL178235A0 (en)	2007-03-08	Bazedoxifene acetate solid dispersion formulations
PT2380575E (pt)	2015-06-17	Acetato de eslicarbazepina e utilização
IL187025A0 (en)	2008-04-13	Hard caramel containing isolmaltulose and process for the manufacture thereof
EP1921066A4 (en)	2010-07-07	PYRIDYLPHENOL COMPOUND AND USE THEREOF
IL183702A0 (en)	2007-09-20	Difluoronucleosides and process for preparation thereof
GB0501348D0 (en)	2005-03-02	Compositions and methods
GB0511807D0 (en)	2005-07-20	Process and compound
IL182970A0 (en)	2007-08-19	Compositions and processes for preparing 13-deoxy-anthracyclines
IL194737A0 (en)	2009-08-03	2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
GB0523637D0 (en)	2005-12-28	Process and compounds
GB0403696D0 (en)	2004-03-24	Process and composition
GB0508495D0 (en)	2005-06-01	Electrode and manufacturing methods
GB0502481D0 (en)	2005-03-16	Cone cleaner